共 8 条
[1]
In silico and in vivo studies of truncated forms of flagellin (FliC) of enteroaggregative Escherichia coli fused to FimH from uropathogenic Escherichia coli as a vaccine candidate against urinary tract infections.[J].Nastaran Sadat Savar;Ali Jahanian-Najafabadi;Mehdi Mahdavi;Mohammad Ali Shokrgozar;Anis Jafari;Saeid Bouzari.Journal of Biotechnology.2014,
[2]
Activity of biapenem (RPX2003) combined with the boronate β-lactamase inhibitor RPX7009 against carbapenem-resistant Enterobacteriaceae.[J].David M. Livermore;Shazad Mushtaq.Journal of Antimicrobial Chemotherapy.2013, 8
[5]
Host–pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.[J].Thomas J. Hannan;Makrina Totsika;Kylie J. Mansfield;Kate H. Moore;Mark A. Schembri;Scott J. Hultgren.FEMS Microbiol Rev.2012, 3

